Ivabrad M 7.5mg/25mg Tablet
By Ivabrad M
Rx
10 Tablet in a Strip

Composition
Ivabradine(7.5mg) + Metoprolol Tartrate(25mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
August, 2025

liver
When taking Ivabrad M 7.5mg/25mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. It is advised to consult your doctor before starting or continuing this treatment to ensure your liver health is monitored closely.

kidney
Ivabrad M 7.5mg/25mg Tablet should be used cautiously in individuals with severe kidney disease. Adjusting the dosage may be necessary. Consult your doctor as there is limited information available for its use in patients with severe kidney disease.

alcohol
It is advised to avoid alcohol while taking Ivabrad M 7.5mg/25mg Tablet. It is not safe to consume alcohol with this medication.

driving
When taking Ivabrad M 7.5mg/25mg Tablet, be cautious while driving as it may cause side effects that can impact your driving ability. You should be especially careful when driving at night due to possible transient luminous phenomena caused by the medication.

pregnancy
It is unsafe to use Ivabrad M 7.5mg/25mg Tablet during pregnancy due to risks to the developing baby. Consult your doctor for alternative options in life-threatening situations.

breastfeeding
Ivabrad M 7.5mg/25mg Tablet is considered safe during breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹231.6
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025